Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV peripheral neuropathy: pathophysiology and clinical implications.

Susan G Dorsey1, Patricia Gonce Morton

  • 1School of Nursing, University of Maryland, Baltimore, 21201, USA. sdorsey@son.umaryland.edu

AACN Clinical Issues
|February 8, 2006
PubMed
Summary

Painful peripheral neuropathy is a common complication of human immunodeficiency virus (HIV) and its treatment. Understanding the pathophysiology of nucleoside-induced neuropathy is crucial for developing new pain management therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The 3P-CP model: Expanding our conceptualization of cancer pain.

Cancer·2025
Same author

Thanks to William O'Connor: Celebrating 35 years of dedication to the American Association of Colleges of Nursing.

Journal of professional nursing : official journal of the American Association of Colleges of Nursing·2025
Same author

Transcriptomic Profiles and Functional Correlates of Cancer-Related Fatigue: A Cross-Sectional Study in Women Undergoing Cancer Treatment.

European journal of cancer care·2025
Same author

Development of a Situation-Specific Biopsychosocial Model of Pain in Heart Failure.

ANS. Advances in nursing science·2025
Same author

Rapid effects of valproic acid on the fetal brain transcriptome: implications for brain development and autism.

Translational psychiatry·2024
Same author

The National Cancer Institute clinical trials planning meeting to address gaps in observational and intervention trials for cancer-related cognitive impairment.

Journal of the National Cancer Institute·2024

Area of Science:

  • Neurology
  • Infectious Diseases
  • Pharmacology

Background:

  • Painful peripheral neuropathy affects up to one in three human immunodeficiency virus (HIV) patients.
  • Highly active antiretroviral therapy (HAART) can cause toxic neuropathy, clinically similar to HIV-induced neuropathy.
  • The primary symptom is severe, persistent pain impacting daily living and mobility.

Purpose of the Study:

  • To provide the latest information on the pathophysiology and clinical implications of HIV peripheral neuropathy.
  • To emphasize the need for understanding nucleoside-induced neuropathy for developing new treatments.
  • To highlight the challenges in managing pain resistant to pharmacological treatments.

Main Methods:

  • Review of current literature on HIV-associated peripheral neuropathy.

Related Experiment Videos

  • Discussion of the pathophysiology of both HIV-induced and nucleoside-induced neuropathies.
  • Analysis of clinical implications and current treatment challenges.

    • Main Results:

    • HIV infection and HAART are significant causes of peripheral neuropathy.
    • Nucleoside-induced neuropathy presents similar symptoms to HIV-induced neuropathy.
    • Current pharmacological treatments are often ineffective for the severe pain associated with this condition.

    Conclusions:

    • Further research into the etiology and pathophysiology of nucleoside-induced peripheral neuropathy is essential.
    • Developing novel therapeutic strategies is critical for alleviating pain and improving quality of life for affected patients.
    • Understanding the mechanisms underlying neuropathy is key to advancing patient care in HIV management.